VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 223 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $235,512 | -10.2% | 26,462 | +2.3% | 0.00% | 0.0% |
| Q1 2024 | $262,154 | -0.8% | 25,879 | -1.5% | 0.00% | 0.0% |
| Q4 2023 | $264,286 | +13.8% | 26,271 | +6.0% | 0.00% | 0.0% |
| Q3 2023 | $232,329 | -61.3% | 24,795 | +1.4% | 0.00% | -60.0% |
| Q2 2023 | $599,808 | +21.5% | 24,452 | +15.3% | 0.01% | +25.0% |
| Q1 2023 | $493,650 | -5.3% | 21,214 | +3.1% | 0.00% | -20.0% |
| Q4 2022 | $521,006 | +36.7% | 20,585 | +4.0% | 0.01% | +25.0% |
| Q3 2022 | $381,000 | -23.5% | 19,785 | +1.2% | 0.00% | -20.0% |
| Q2 2022 | $498,000 | +9.5% | 19,550 | +10.5% | 0.01% | +25.0% |
| Q1 2022 | $455,000 | -38.2% | 17,689 | +0.6% | 0.00% | -33.3% |
| Q4 2021 | $736,000 | -4.5% | 17,577 | -0.8% | 0.01% | 0.0% |
| Q3 2021 | $771,000 | -6.1% | 17,711 | +1.9% | 0.01% | -14.3% |
| Q2 2021 | $821,000 | – | 17,375 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $39,700,000 | 30.52% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $565,858,000 | 4.50% |
| Zebra Capital Management LLC | 25,419 | $647,000 | 1.90% |
| Alaska Permanent Fund Corp | 2,300,000 | $58,581,000 | 0.84% |
| CLARK ESTATES INC/NY | 180,000 | $4,585,000 | 0.79% |
| Temasek Holdings (Private) Ltd | 5,602,553 | $142,697,025 | 0.78% |
| SECTOR GAMMA AS | 110,223 | $2,807,000 | 0.63% |
| Avidity Partners Management LP | 758,211 | $19,312,000 | 0.44% |
| New Vernon Capital Holdings II LLC | 14,501 | $369,000 | 0.30% |
| DUALITY ADVISERS, LP | 116,415 | $2,965,000 | 0.29% |